Stock Surge Alert: WBX +47%, IOT +29%, MRNA +22% on EPS Revisions
Five stocks detected by EPS revision screener rallied sharply after estimates were raised, led by Wallbox (WBX) surging 47.1% on a 10.6 percentage point upgrade. Samsara (IOT) gained 29.4% and Moderna (MRNA) rose 21.6%, while Newsmax (NMAX) and Rubrik (RBRK) each climbed 20.8%. The moves reflect strong market validation of upward earnings revisions across tech and healthcare.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| WBX | Technology | 2026-06-30 | +10.6pp | +47.1% |
| IOT | Technology | 2026-06-25 | N/A | +29.4% |
| MRNA | Healthcare | 2026-06-28 | N/A | +21.6% |
| NMAX | Communication Services | 2026-06-28 | +217.8pp | +20.8% |
| RBRK | Technology | 2026-06-28 | N/A | +20.8% |
Why did WBX stock jump in July 2026?
WBX jumped 47.1% (from $3.82 to $5.62) after analysts raised its forward EPS growth estimate from 50.6% to 61.3% on June 30.
The surge was reinforced by a July 2 announcement of an ~$11.8 million equity raise plus an additional $4 million investment, signaling strong institutional confidence. The screener caught the revision early, and the subsequent 47% rally confirms the EPS upgrade as the primary catalyst.
WBX EPS revision history → · Screener snapshot from 2026-06-30 →
FAQ: WBX
Why did WBX stock jump in July 2026?
WBX jumped 47.1% after analysts raised its forward EPS growth estimate from 50.6% to 61.3% on June 30, followed by an equity raise and additional investment on July 2.
Is WBX a buy after the rally?
The rally was driven by a significant EPS revision and institutional investment, but investors should consider the 47% gain may already price in the upgrade.
What is WBX's EPS growth estimate after the revision?
After the revision on June 30, WBX's forward EPS growth estimate stands at 61.3%, up from 50.6%.
Why did IOT stock jump in July 2026?
IOT jumped 29.4% (from $28.98 to $37.51) after its forward EPS growth estimate was revised upward to 27.6% on June 25.
No specific news followed, but the technology sector saw broad demand for growth stocks with improving margins. The screener detected the revision early, and the price action confirmed the upgrade was the main driver.
IOT EPS revision history → · Screener snapshot from 2026-06-25 →
FAQ: IOT
Why did IOT stock jump in late June 2026?
IOT jumped 29.4% after its forward EPS growth estimate was raised to 27.6% on June 25, without any accompanying news, indicating the revision itself spurred buying.
What is IOT's forward EPS growth estimate?
IOT's forward EPS growth estimate is 27.6% as of the revision on June 25.
Is IOT a buy after the rally?
The 29.4% gain reflects strong market reception to the upgrade, but investors should monitor whether future earnings confirm the revised growth trajectory.
Why did MRNA stock jump in July 2026?
MRNA jumped 21.6% (from $67.27 to $81.80) after its forward EPS growth estimate was revised upward to 45.4% on June 28.
No earnings-related news appeared in the detection window, but healthcare sector momentum and renewed interest in biotech likely amplified the move. The screener caught the EPS upgrade before the rally took hold.
MRNA EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: MRNA
Why did MRNA stock jump in late June 2026?
MRNA jumped 21.6% after its forward EPS growth estimate was raised to 45.4% on June 28, with no specific news catalyst other than the revision.
What is MRNA's EPS growth estimate?
MRNA's forward EPS growth estimate now stands at 45.4% after the June 28 revision.
What caused MRNA's surge?
The surge was driven by an upward EPS revision, likely combined with favorable sector trends in healthcare and biotech.
Why did NMAX stock jump in July 2026?
NMAX jumped 20.8% (from $7.49 to $9.05) after analysts dramatically raised its forward EPS growth estimate from 159.1% to 376.9% on June 28.
This 217.8 percentage point revision is one of the largest detected, reflecting a major inflection in earnings expectations. No news surfaced, but the magnitude of the upgrade alone attracted buyers.
NMAX EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: NMAX
Why did NMAX stock surge in June 2026?
NMAX surged 20.8% after its forward EPS growth estimate was raised from 159.1% to 376.9% on June 28, a massive 217.8 percentage point upgrade.
What is NMAX's EPS growth estimate after the revision?
NMAX's forward EPS growth estimate is 376.9%, up from 159.1% after the June 28 revision.
How much did NMAX's EPS estimate increase?
NMAX's EPS estimate increased by 217.8 percentage points from 159.1% to 376.9%.
Why did RBRK stock jump in July 2026?
RBRK jumped 20.8% (from $72.33 to $87.36) after its forward EPS growth estimate was raised to 106.4% on June 28.
No news accompanied the move, but demand for data security and cloud infrastructure stocks provided tailwinds. The screener identified the estimate revision as an early signal, and the subsequent rally validated the upgrade.
RBRK EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: RBRK
Why did RBRK stock jump in June 2026?
RBRK jumped 20.8% after its forward EPS growth estimate was raised to 106.4% on June 28, with no additional news catalysts.
What is RBRK's EPS growth estimate?
RBRK's forward EPS growth estimate is 106.4% after the June 28 revision.
Is RBRK a buy after the rally?
The rally reflects strong market confidence in the EPS upgrade, but potential buyers should consider the high growth estimate and sector trends.
Today's EPS revision driven rallies signal strong investor appetite for growth stocks with improving fundamentals, particularly in technology and healthcare sectors where estimates are being lifted. The magnitude of the upgrades—from 10 to 218 percentage points—underscores a broad-based earnings recovery story.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →